Early endocrine, bone, and inflammatory responses to microwave ablation for hyperparathyroidism: preliminary study
By
Ying Wei
Zhenlong Zhao
Jie Wu
Shiliang Cao
Na Yu
Wenjia Cai
Yan Li
Lili Peng
Ming’an Yu
July 7, 2026
Clinical Scorecard: Initial hormonal, skeletal, and inflammatory responses following microwave ablation in hyperparathyroidism: a preliminary investigation
At a Glance
Category Detail
Condition Hyperparathyroidism Key Mechanisms Microwave ablation induces rapid biochemical normalization and early skeletal and inflammatory changes. Target Population Patients with primary and secondary hyperparathyroidism. Care Setting Department of Interventional Medicine, China-Japan Friendship Hospital.
Key Highlights
Nineteen patients underwent ultrasound-guided microwave ablation. Significant reductions in serum intact parathyroid hormone (iPTH) and calcium levels observed. Bone turnover markers showed changes post-ablation, including increased PINP and decreased FGF-23. Inflammatory markers peaked at day 1 and decreased by month 1. No severe hypocalcemia occurred; transient hoarseness noted in two patients. Guideline-Based Recommendations
Diagnosis
Diagnosis of hyperparathyroidism confirmed through biochemical markers and imaging. Management
Microwave ablation is a minimally invasive treatment option for hyperparathyroidism. Monitoring & Follow-up
Monitor serum iPTH, calcium, phosphate, and inflammatory markers post-ablation. Risks
Transient hoarseness reported; no severe complications noted. Patient & Prescribing Data
Nineteen patients with hyperparathyroidism, including 14 with primary and 5 with secondary hyperparathyroidism.
Microwave ablation leads to rapid biochemical changes and potential symptomatic relief.
Clinical Best Practices
Ensure proper patient selection based on inclusion and exclusion criteria. Utilize ultrasound guidance for safe and effective microwave ablation. Conduct follow-up assessments to evaluate biochemical and symptomatic changes. Related Resources & Content
